PRCT:NSD-Procept Biorobotics Corp (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 63.17

Change

-0.31 (-0.49)%

Market Cap

USD 3.54B

Volume

0.61M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

+0.57 (+0.49%)

USD 46.18B
ALGN Align Technology Inc

-0.42 (-0.17%)

USD 18.26B
PODD Insulet Corporation

+4.79 (+2.40%)

USD 13.96B
SWAV Shockwave Medical Inc

N/A

USD 12.57B
BRKR Bruker Corporation

-0.52 (-0.78%)

USD 10.11B
MASI Masimo Corporation

+0.78 (+0.60%)

USD 7.22B
TMDX TransMedics Group Inc

-4.96 (-3.44%)

USD 4.52B
AXNX Axonics Modulation Technologie..

+0.25 (+0.37%)

USD 3.43B
IRTC iRhythm Technologies Inc

-2.35 (-2.23%)

USD 3.09B
LIVN LivaNova PLC

+0.53 (+0.95%)

USD 2.93B

ETFs Containing PRCT

FFTY Innovator IBD® 50 ETF 3.19 % 0.80 %

-0.37 (0.47%)

USD 0.09B
W311:XETRA HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

+0.05 (+0.47%)

USD 0.02B
W311:F HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

+0.05 (+0.47%)

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

+0.06 (+0.47%)

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

+0.03 (+0.47%)

N/A
WELP:LSE HAN-GINS Indxx Healthcare.. 1.57 % 0.00 %

+4.90 (+0.47%)

USD 0.02B
DTEC ALPS Disruptive Technolog.. 1.32 % 0.00 %

+0.02 (+0.47%)

USD 0.10B
FYC First Trust Small Cap Gro.. 0.83 % 0.70 %

+0.28 (+0.47%)

USD 0.27B
FYX First Trust Small Cap Cor.. 0.43 % 0.63 %

+0.36 (+0.47%)

USD 0.83B
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

-0.06 (0.47%)

USD 0.25B
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

+0.04 (+0.47%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.73% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.73% 89% A- 92% A
Trailing 12 Months  
Capital Gain 82.31% 96% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.31% 96% N/A 94% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 12.93% 64% D 71% C-
Dividend Return 12.93% 64% D 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 35.25% 82% B 53% F
Risk Adjusted Return 36.69% 87% B+ 70% C-
Market Capitalization 3.54B 94% A 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector